The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (22): 3196-3201.doi: 10.3969/j.issn.1006-5725.2024.22.013
• Clinical Research • Previous Articles Next Articles
Juanjuan FENG,Zexing CHENG,Lu XIAO()
Received:
2024-03-28
Online:
2024-11-25
Published:
2024-11-25
Contact:
Lu XIAO
E-mail:18012125683@189.cn
CLC Number:
Juanjuan FENG,Zexing CHENG,Lu XIAO. The clinical value of NLRP3 inflammasome level combined with ECP/MPO ratio in predicting the recurrence of chronic sinusitis after endoscopic sinus surgery[J]. The Journal of Practical Medicine, 2024, 40(22): 3196-3201.
Tab.2
Comparison of clinical data between the twos group"
组别 | 例数 | 年龄(岁) | 性别/[例(%)] | 吸烟史/[例(%)] | 病程/年 | BMI/(kg/m2) | 手术时间/[例(%)] | ||
---|---|---|---|---|---|---|---|---|---|
男 | 女 | ≥ 2 h | < 2 h | ||||||
非复发组 | 123 | 59.81 ± 12.57 | 76(61.79) | 47(38.21) | 41(33.33) | 5.43 ± 0.44 | 24.19 ± 2.43 | 57(46.34) | 66(53.66) |
复发组 | 78 | 60.43 ± 12.88 | 50(64.10) | 28(35.90) | 25(32.05) | 5.39 ± 0.46 | 24.31 ± 2.52 | 34(43.59) | 44(56.41) |
t/χ2值 | 0.338 | 0.109 | 0.036 | 0.617 | 0.336 | 0.146 | |||
P值 | 0.736 | 0.741 | 0.850 | 0.538 | 0.737 | 0.703 |
Tab.3
Analyzes the influencing factors"
影响因素 | b | Sb | Wald χ2 | P值 | OR | 95%CI |
---|---|---|---|---|---|---|
NLRP3炎性小体水平 | 1.368 | 0.371 | 13.596 | < 0.001 | 3.927 | 1.727 ~ 8.934 |
ECP/MPO比值 | 1.205 | 0.343 | 12.342 | < 0.001 | 3.337 | 1.467 ~ 7.590 |
鼻窦CT评分 | 1.053 | 0.378 | 7.760 | < 0.001 | 2.866 | 1.260 ~ 6.520 |
Lund-Kennedy 评分 | 1.138 | 0.446 | 6.511 | < 0.001 | 3.121 | 1.372 ~ 7.099 |
免疫球蛋白E | 1.424 | 0.507 | 7.889 | < 0.001 | 4.154 | 1.826 ~ 9.449 |
1 |
BLEIER B S, PAZ-LANSBERG M. Acute and chronic sinusitis[J]. Med Clin North Am, 2021,105(5):859-870. doi:10.1016/j.mcna.2021.05.008
doi: 10.1016/j.mcna.2021.05.008 |
2 |
ZHENG J, YU L, HU W, et al. Systematic review and meta-analysis of the curative effects and safety of endoscopic sinus surgery in children with chronic sinusitis with nasal polyps[J]. Transl Pediatr, 2022,11(7):1171-1181. doi:10.21037/tp-22-189
doi: 10.21037/tp-22-189 |
3 |
WANG X, SIMA Y, ZHAO Y, et al. Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors[J]. J Allergy Clin Immunol, 2023,151(2):458-468. doi:10.1016/j.jaci.2022.10.010
doi: 10.1016/j.jaci.2022.10.010 |
4 |
GEVAERT P, HAN J K, SMITH S G, et al. The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2022,12(11):1413-1423. doi:10.1002/alr.22994
doi: 10.1002/alr.22994 |
5 | 林秋红,肖祥,张书嘉,等. 鼻息肉组织中嗜酸性阳离子蛋白/髓过氧化物酶、趋化因子配体4、免疫球蛋白E对慢性鼻窦炎伴鼻息肉术后复发的预测价值[J]. 中国医药导报,2022,19(27):106-109,118. |
6 |
HUANG Y, XU W, ZHOU R. NLRP3 inflammasome activation and cell death[J]. Cell Mol Immunol, 2021,18(9):2114-2127. doi:10.1038/s41423-021-00740-6
doi: 10.1038/s41423-021-00740-6 |
7 |
QIN Y, LI Q, LIANG W, et al. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation[J]. Nat Commun, 2021,12(1):4794. doi:10.1038/s41467-021-25033-4
doi: 10.1038/s41467-021-25033-4 |
8 |
SABNIS R W. Pyridazine derivatives as NLRP3 inhibitors for treating asthma, COPD, Parkinson's disease, and Alzheimer's disease[J]. ACS Med Chem Lett, 2023,14(8):1047-1048. doi:10.1021/acsmedchemlett.3c00311
doi: 10.1021/acsmedchemlett.3c00311 |
9 |
中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志,2019,54(2):81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001
doi: 10.3760/cma.j.issn.1673-0860.2019.02.001 |
10 |
MIGLANI A, SOLER Z M, SMITH T L, et al. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis[J]. Int Forum Allergy Rhinol, 2023,13(2):116-128. doi:10.1002/alr.23059
doi: 10.1002/alr.23059 |
11 |
LEE S, FERNANDEZ J, MIRJALILI S A, et al. Pediatric paranasal sinuses-Development, growth, pathology, & functional endoscopic sinus surgery[J]. Clin Anat, 2022,35(6):745-761. doi:10.1002/ca.23888
doi: 10.1002/ca.23888 |
12 |
KATO A, PETERS A T, STEVENS W W, et al. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches[J]. Allergy, 2022,77(3):812-826. doi:10.1111/all.15074
doi: 10.1111/all.15074 |
13 |
LOURIJSEN E S, REITSMA S, VLEMING M, et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: A multicentre, randomised, controlled trial[J]. Lancet Respir Med, 2022,10(4):337-346. doi:10.1016/S2213-2600(21)00457-4
doi: 10.1016/S2213-2600(21)00457-4 |
14 |
MITTAL Y, PRADHAN P, SARKAR S, et al. Posterior nasal nerve neurectomy for the treatment of chronic rhinosinusitis with nasal polyposis: A randomized controlled trial[J]. Eur Arch Otorhinolaryngol, 2023,280(4):1785-1791. doi:10.1007/s00405-022-07722-y
doi: 10.1007/s00405-022-07722-y |
15 |
MOHAMED W S, EL G M, SABER S F, et al. Risk factors for recurrence of nasal polyps after endoscopic sinus surgery in patients with allergic chronic rhino sinusitis[J]. Indian J Otolaryngol Head Neck Surg, 2023,75(4):3379-3385. doi:10.1007/s12070-023-03988-8
doi: 10.1007/s12070-023-03988-8 |
16 | LEGGEWIE B, GABRIELPILLAI J, SRTIETH S. Management strategies for chronic rhinosinusitis with nasal polyps[J]. HNO, 2022,70(1):79-86. |
17 |
BAI J, HUANG J H, PRICE C, et al. Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2022,150(2):352-361. doi:10.1016/j.jaci.2022.02.029
doi: 10.1016/j.jaci.2022.02.029 |
18 |
BACHERT C, HAN J K, WAGENMANN M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management[J]. J Allergy Clin Immunol, 2021,147(1):29-36. doi:10.1016/j.jaci.2020.11.013
doi: 10.1016/j.jaci.2020.11.013 |
19 | PFFAAR O, BEULE A G, LAUDIEN M, et al. Treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) with monoclonal antibodies (biologics): S2k guideline of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), and the German College of General Practitioners and Family Physicians (DEGAM)[J]. HNO, 2023,71(4):256-263. |
20 |
FORSTER-RUHRMANN U, SZCZEPEK A J, PIERCHALLA G, et al. Chemokine expression-based endotype clustering of chronic rhinosinusitis[J]. J Pers Med, 2022,12(4):646. doi:10.3390/jpm12040646
doi: 10.3390/jpm12040646 |
21 |
STEIN E, SCHNEIDER A L, HARMON R, et al. Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype[J]. Int Forum Allergy Rhinol, 2023,13(1):15-24. doi:10.1002/alr.23042
doi: 10.1002/alr.23042 |
22 |
SEJIMA T, HOLTAPPELS G, KIKUCHI H, et al. Cytokine profiles in Japanese patients with chronic rhinosinusitis[J]. Allergol Int, 2012,61(1):115-122. doi:10.2332/allergolint.10-oa-0290
doi: 10.2332/allergolint.10-oa-0290 |
23 |
MIN J Y, KIM J Y, SUNG C M, et al. Inflammatory Endotypes of Chronic Rhinosinusitis in the Korean Population: Distinct Expression of Type 3 Inflammation[J]. Allergy Asthma Immunol Res, 2023,15(4):437-450. doi:10.4168/aair.2023.15.4.437
doi: 10.4168/aair.2023.15.4.437 |
24 |
郑铭,王敏,李颖,等. 慢性鼻窦炎伴鼻息肉的免疫炎性标志物表达及其对术后复发的预测价值[J]. 中华耳鼻咽喉头颈外科杂志,2019,54(3):174-180. doi:10.3760/cma.j.issn.1673-0860.2019.03.003
doi: 10.3760/cma.j.issn.1673-0860.2019.03.003 |
25 |
LYU D, WANG F, ZHANG M, et al. Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway[J]. Psychopharmacology (Berl), 2022,239(10):3201-3212. doi:10.1007/s00213-022-06201-w
doi: 10.1007/s00213-022-06201-w |
26 |
CHANG L, WU H, HUANG W, et al. IL-21 induces pyroptosis of Treg cells via Akt-mTOR-NLRP3-caspase 1 axis in eosinophilic chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2023,152(3):641-655. doi:10.1016/j.jaci.2023.04.013
doi: 10.1016/j.jaci.2023.04.013 |
27 |
ZHONG B, SUN S, TAN K S, et al. Hypoxia-inducible factor 1alpha activates the NLRP3 inflammasome to regulate epithelial differentiation in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2023,152(6):1444-1459. doi:10.1016/j.jaci.2023.09.020
doi: 10.1016/j.jaci.2023.09.020 |
28 |
CURE M C, CURE E. Prolonged NHE activation may be both cause and outcome of cytokine release syndrome in COVID-19[J]. Curr Pharm Des, 2022,28(22):1815-1822. doi:10.2174/1381612828666220713121741
doi: 10.2174/1381612828666220713121741 |
29 |
WANG Y, CHEN S, WANG W, et al. Role of P2X7R in eosinophilic and non‑eosinophilic chronic rhinosinusitis with nasal polyps[J]. Mol Med Rep, 2021,24(1):521. doi:10.3892/mmr.2021.12160
doi: 10.3892/mmr.2021.12160 |
30 |
易莎,胡楠,李粤,等. 过氧化物酶体增殖物激活受体-γ对P.acnes诱导的人角质形成细胞焦亡、增殖及凋亡的影响[J]. 实用医学杂志,2023,39(16):2043-2049. doi:10.3969/j.issn.1006-5725.2023.16.006
doi: 10.3969/j.issn.1006-5725.2023.16.006 |
31 |
杜志宏,于亚峰. NLRP3炎性小体在嗜酸粒细胞性鼻息肉发病及复发中的作用[J]. 山东大学耳鼻喉眼学报, 2016, 30(1):31-35. doi:10.6040/j.issn.1673-3770.0.2015.318
doi: 10.6040/j.issn.1673-3770.0.2015.318 |
32 |
ZHONG B, DU J, LIU F, et al. Hypoxia-induced factor-1alpha induces NLRP3 expression by M1 macrophages in noneosinophilic chronic rhinosinusitis with nasal polyps[J]. Allergy, 2021,76(2):582-586. doi:10.1111/all.14571
doi: 10.1111/all.14571 |
33 |
ZHENG L, CHEN Z, JIN J, et al. The efficacy of steroid-eluting stents on the local inflammation of chronic rhinosinusitis with nasal polyposis after endoscopic sinus surgery: a multicenter prospective longitudinal study[J]. Eur Arch Otorhinolaryngol, 2023,280(12):5417-5431. doi:10.1007/s00405-023-08158-8
doi: 10.1007/s00405-023-08158-8 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||